Applications of Phentolamine in Industrial Manufacturing

As a direct manufacturer of Phentolamine, we supply this raw material into core pharmaceutical and veterinary supply chains. Our production supports formulation processes that require precise control of composition, stringent quality assurance, and full compliance with regional regulatory systems.

1. Synthesis of Injectable Vasodilator Pharmaceuticals

Phentolamine serves as a key active ingredient in the formulation of vasodilator injectable preparations, particularly for managing hypertensive emergencies and diagnosis of pheochromocytoma. Downstream manufacturers dissolve Phentolamine mesylate powder with sterile water under aseptic production environments, apply rigorous filtration, and run lyophilization processes to ensure stability. Batch QC requires adherence to USP and EP monographs for identity, purity, and residual solvent content. Manufacturers maintain closed-loop traceability from raw material specification through finished vial serialization.

Industry compliance standards

• United States Pharmacopoeia (USP) 42/NF 37
• European Pharmacopoeia (EP) 10.0
• cGMP (Current Good Manufacturing Practice) for injectable drugs
• ICH Q3A/Q3C guidelines for impurities and solvents

Typical usage ratio

• Standard API load: 5–15 mg per dose (concentration varies based on product labeling and market)
• Formulators adjust API content within 90–110% range depending on region-specific potency standards

Downstream process integration

• Weighing and dissolving in sterile compounding suites
• Terminal filtration before fill-finish
• Controlled freeze-drying for stability extension
• Batch release after sterility and content uniformity testing

Final product types

• Pre-filled ampoules for hospital use
• Lyo vials for reconstitution
• Hospital pharmacy multi-dose vials

2. Oral Pharmaceutical Formulations for Erectile Dysfunction

Phentolamine is incorporated into oral solid dosage forms for adjunct therapy in erectile dysfunction, often in combination tablet manufacturing. Formulation technologists granulate the raw API with excipients targeting rapid dissolution profiles and compress the blend into blister-packed tablets. Downstream quality units must validate every batch for content uniformity and dissolution, referencing the local pharmacopoeial release criteria.

Industry compliance standards

• Chinese Pharmacopoeia (ChP) 2020 for oral API prep
• Good Manufacturing Practice (GMP) for pharmaceutical tablets (China, India, EU)
• ICH Q6A for specifications
• Labeling compliance with SFDA/NMPA or EMA directives

Typical usage ratio

• Typical API load per tablet: 20–40 mg
• Adjustable up to 60 mg in combination or as dictated by market-specific maximum daily dose

Downstream process integration

• Blending with flow agents and disintegrants
• High-shear granulation or direct compression
• Film coating for taste masking
• Serialisation for anti-counterfeit control in final packaging

Final product types

• Blister-packed tablets (single and combination packs)
• Bottled capsules for clinical distribution

3. Veterinary Parenteral Preparations

Phentolamine is approved in certain markets for veterinary use, particularly in large animal medicine for management of hypertensive episodes and reversal of certain anesthetics. Veterinary compounding facilities formulate sterile injectable solutions by solubilizing the API and monitoring final osmolarity and pH profiles to meet species-specific tolerances. Vials are batch-sterilized and labeled following VICH and regional MRLs.

Industry compliance standards

• VICH GL9 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• US FDA Center for Veterinary Medicine (CVM) guidelines
• European Medicines Agency (EMA) veterinary guidelines
• Maximum Residue Limit (MRL) directives by market

Typical usage ratio

• Dosage range: 0.5–2 mg/kg body weight per injection
• Final solution concentration based on animal weight and administration modality

Downstream process integration

• Weight-based dosing solution preparation
• Sterile filtration and vial filling
• Label content verified for species-use restrictions
• Post-fill batch sterility and stability testing

Final product types

• Veterinary injectable vials
• Ready-to-use syringes for field veterinarians

4. Diagnostic Test Reagent Manufacturing

Analytical-grade Phentolamine is utilized in specialty diagnostic reagent production, specifically as a calibrator or functional ingredient in diagnostic challenge tests which assess catecholamine release or vascular reactivity in clinical labs. Downstream reagent manufacturers require the raw material in high purity, with stringent endotoxin or bioburden controls. Phentolamine is dissolved for use in single-use diagnostic kits and validated for trace analyte interference.

Industry compliance standards

• ISO 13485 for medical device quality management
• IVD Directive 98/79/EC for in vitro diagnostic medical devices
• Clinical Laboratory Standards Institute (CLSI) protocols
• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) for chemical safety

Typical usage ratio

• Standard reagent concentration: 0.05–1.0 mg/mL depending on protocol sensitivity
• Adjusted according to device calibration requirements and target detection limits

Downstream process integration

• Formulation into buffer solutions or reaction mixes
• Aliquoting into ready-to-use ampoules for diagnostic kits
• QC for bioburden, pH, and chemical interference prior to release
• Labeling per regulatory batch traceability standards

Final product types

• Single-use diagnostic kits for hospital labs
• Reagent ampoules for research institutes
• Pre-packed calibrators for analyzers